WallStreetZenWallStreetZen

NASDAQ: SNTI
Senti Biosciences Inc Stock

$2.55-0.29 (-10.21%)
Updated Jul 18, 2024
SNTI Price
$2.55
Fair Value Price
N/A
Market Cap
$11.67M
52 Week Low
$2.11
52 Week High
$10.90
P/E
-0.18x
P/B
0.21x
P/S
13.52x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.28M
Earnings
-$64.45M
Gross Margin
100%
Operating Margin
-5,054.67%
Profit Margin
-5,054.7%
Debt to Equity
0.82
Operating Cash Flow
-$48M
Beta
1.24
Next Earnings
Aug 9, 2024
Ex-Dividend
N/A
Next Dividend
N/A

SNTI Overview

Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cells to target particularly challenging liquid and solid tumor oncology indications. The company's lead programs include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate acute myeloid leukemia (AML) cells, while sparing the healthy bone marrow; and SENTI-301, a multi-armed off-the-shelf CAR-NK cell therapy designed for the treatment of hepatocellular carcinoma (HCC). It also develops SENTI-401, a Logic Gated (NOT) off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer (CRC) cells, while sparing healthy cells in the body. The company was founded in 2016 and is based in South San Francisco, California.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SNTI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SNTI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SNTI is good value based on its book value relative to its share price (0.21x), compared to the US Biotechnology industry average (6.19x)
P/B vs Industry Valuation
SNTI is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SNTI due diligence checks available for Premium users.

Be the first to know about important SNTI news, forecast changes, insider trades & much more!

Valuation

SNTI price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.18x
Industry
-26.99x
Market
29.86x

SNTI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.21x
Industry
6.19x
SNTI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SNTI's financial health

Profit margin

Revenue
$0.0
Net Income
-$12.1M
Profit Margin
0%
SNTI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SNTI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$102.2M
Liabilities
$46.1M
Debt to equity
0.82
SNTI's short-term assets ($55.67M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SNTI's short-term assets ($55.67M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SNTI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$11.7M
Investing
-$15.0k
Financing
$0.0
SNTI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SNTI vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
SNTI$11.67M-10.05%-0.18x0.21x
NRSN$11.69M-3.55%-1.03x-6.64x
LUMO$11.77M-3.33%-0.32x0.67x
ERNA$11.52M+5.45%-0.50x-3.38x
TRAW$11.39M+0.22%-0.52x1.89x

Senti Biosciences Stock FAQ

What is Senti Biosciences's quote symbol?

(NASDAQ: SNTI) Senti Biosciences trades on the NASDAQ under the ticker symbol SNTI. Senti Biosciences stock quotes can also be displayed as NASDAQ: SNTI.

If you're new to stock investing, here's how to buy Senti Biosciences stock.

What is the 52 week high and low for Senti Biosciences (NASDAQ: SNTI)?

(NASDAQ: SNTI) Senti Biosciences's 52-week high was $10.90, and its 52-week low was $2.11. It is currently -76.61% from its 52-week high and 20.8% from its 52-week low.

How much is Senti Biosciences stock worth today?

(NASDAQ: SNTI) Senti Biosciences currently has 4,575,502 outstanding shares. With Senti Biosciences stock trading at $2.55 per share, the total value of Senti Biosciences stock (market capitalization) is $11.67M.

Senti Biosciences stock was originally listed at a price of $99.80 in May 26, 2021. If you had invested in Senti Biosciences stock at $99.80, your return over the last 3 years would have been -97.44%, for an annualized return of -70.55% (not including any dividends or dividend reinvestments).

How much is Senti Biosciences's stock price per share?

(NASDAQ: SNTI) Senti Biosciences stock price per share is $2.55 today (as of Jul 18, 2024).

What is Senti Biosciences's Market Cap?

(NASDAQ: SNTI) Senti Biosciences's market cap is $11.67M, as of Jul 19, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Senti Biosciences's market cap is calculated by multiplying SNTI's current stock price of $2.55 by SNTI's total outstanding shares of 4,575,502.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.